Profil
Joshua Rosenblat is the founder of 1907 Foundation.
He is currently working as an Assistant Professor at the University of Toronto, a Clinical & Technical Advisor at iGan Partners, and as the Chief Medical & Scientific Officer at Braxia Scientific Corp.
He completed his undergraduate degree at the University of Toronto and his doctorate at the University of Western Ontario.
Aktiva positioner av Joshua Rosenblat
| Företag | Position | Start |
|---|---|---|
| CHAMPIGNON BRANDS | Teknisk/Vetenskaplig/F&U Direktör | 2021-05-28 |
iGan Partners
iGan Partners Investment ManagersFinance iGan Partners invests in companies located in Canada. The firm targets companies operating in the fields of healthcare technology, digital therapeutics, medical devices,AI- enabled MedTech and digital health sector. It provides financing for seed and early stage capital requirements. It also makes follow-on-investments. | Konsult / Rådgivare | - |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
1907 Foundation | Grundare | - |
Joshua Rosenblats utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
iGan Partners
iGan Partners Investment ManagersFinance iGan Partners invests in companies located in Canada. The firm targets companies operating in the fields of healthcare technology, digital therapeutics, medical devices,AI- enabled MedTech and digital health sector. It provides financing for seed and early stage capital requirements. It also makes follow-on-investments. | Finance |
Braxia Scientific Corp.
Braxia Scientific Corp. BiotechnologyHealth Technology Develops ketamine treatment and psychedelic medicine for mental health treatments | Health Technology |
1907 Foundation |
















